JKK: Jurnal Kesehatan & Kedokteran

Loading Experience

##navigation.skip##
Home Peer Review Process

Peer Review Process

JOURNAL INFORMATION / EDITORIAL POLICY

Peer Review Process

Rigorous scientific evaluation, clinical safety, and research integrity at every stage of publication.

Double-Blind Review
Independent Evaluation
Editorial Integrity
EDITORIAL POLICY

Scientific rigor and patient safety in every submission

Jurnal Kesehatan & Kedokteran is committed to upholding the highest standards of scientific rigor, clinical safety, epidemiological validity, and research integrity. Given the direct implications for human health and clinical practice, all manuscripts undergo comprehensive editorial assessment and stringent peer review.

REVIEW MODEL

Double-Blind Peer Review

Jurnal Kesehatan & Kedokteran adopts a double-blind peer-review system, in which the identities of authors and reviewers remain confidential to one another throughout the evaluation process. This ensures decisions are grounded strictly on methodological rigor, statistical integrity, and clinical relevance.

01

Initial Editorial Screening

Every submission is evaluated by a Medical Editor for:

The initial assessment considers
  • scope match and relevance to clinical medicine or public health;
  • clarity of hypotheses and clinical or epidemiological objectives;
  • research design appropriateness and validity of statistical analysis;
  • formal ethical clearance from an accredited institutional review board;
  • compliance with reporting standards (e.g., CONSORT, STROBE, PRISMA);
  • completeness of references and adherence to ICMJE guidelines; and
  • similarity screening for textual duplication.

Submissions lacking valid ethical approval, displaying fatal methodological errors, or lacking clinical relevance are rejected at this stage (immediate desk rejection).

02

External Peer Review

Manuscripts meeting initial benchmarks are assigned to at least two independent peer reviewers with expertise in the clinical specialty, biomedical domain, or biostatistics.

In instances of split recommendations, a third expert opinion or specialized statistical review is commissioned.

03

Review Criteria

Reviewers evaluate manuscripts according to the following criteria:

Scientific and Clinical Significance

Contributes meaningfully to clinical management, disease prevention, pathology, or healthcare delivery.

Methodological Validity

Rigorous detailing of sample calculation, inclusion/exclusion criteria, experimental procedures, analytical protocols, and minimization of bias.

Statistical Rigor

Proper presentation of statistical power, effect sizes, confidence intervals, and exact p-values.

Ethical Compliance

Transparent documentation of institutional ethics committee approval and patient informed consent.

Evidence-Based Interpretation

Balanced discussion of results grounded in international clinical literature, clearly articulating clinical limitations.

04

Reviewer Responsibilities

Reviewers must provide objective, evidence-based assessments; maintain strict confidentiality over patient and experimental data; alert editors to any signs of data manipulation or figure alteration; declare all competing interests (especially pharmaceutical or medical device ties); and adhere to review timelines.

05

Editorial Decision

The Editor-in-Chief determines the final outcome based on peer feedback.

Possible decisions include
01

Accept

02

Accept with Minor Revisions

03

Major Revisions / Re-review

04

Reject

Editorial decisions are determined by the Editor-in-Chief based on peer feedback.
06

Revision Process

Authors must supply a revised manuscript alongside an itemized response detailing each modification, providing point-by-point clinical counterarguments where appropriate.

07

Review Timeline

Standard peer review operates under structured timelines.

An expedited Fast-Track Review workflow is reserved for public health emergencies or major health crises.

08

Confidentiality and Conflicts of Interest

Patient records and pre-publication research data are treated as strictly confidential medical material.

09

Editorial Independence

Editorial decisions are completely independent of commercial pharmaceutical interests, device manufacturers, or institutional funders.

10

Editorial Commitment

Jurnal Kesehatan & Kedokteran safeguards the integrity of biomedical literature to protect patient outcomes and health policies.